Noveris Health Sciences is trading 5.3% up at CA$1.55 today as the stock recovers from recent downward pressure.
- The move comes without any fresh company-specific news or regulatory filings on July 16, suggesting a technical bounce following recent declines.
- Previous corporate updates from April and June 2026, including a stem cell acquisition term sheet and AGM scheduling, were already known to the market.